Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus

PURPOSE: The clinical benefit of targeted molecular therapy (TMT) in renal cell carcinoma (RCC) with an inferior vena cava (IVC) tumor thrombus remains controversial. The aim of this study was to investigate the effects of presurgical TMT on the heights and levels of IVC thrombi, and to assess its i...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Cheng, Gu, Liangyou, Wang, Lei, Huang, Qingbo, Wang, Baojun, Guo, Gang, Fan, Yang, Gao, Yu, Ma, Xin, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898583/
https://www.ncbi.nlm.nih.gov/pubmed/29670375
http://dx.doi.org/10.2147/OTT.S158114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898583/
https://www.ncbi.nlm.nih.gov/pubmed/29670375
http://dx.doi.org/10.2147/OTT.S158114

Ejemplares similares